EPAC2: A new and promising protein for glioma pathogenesis and therapy
Gliomas are prime brain cancers which are initiated by malignant modification of neural stem cells, progenitor cells and differentiated glial cells such as astrocyte, oligodendrocyte as well as ependymal cells. Exchange proteins directly activated by cAMP (EPACs) are crucial cyclic adenosine 3'...
Saved in:
Main Author: | Seidu A. Richard (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
by: Yunfeng Pan, et al.
Published: (2022) -
Epac signaling protein ligands as tools for studying their biological activity and creating new original drugs
by: G. V. Mokrov, et al.
Published: (2020) -
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
by: Jiang Y, et al.
Published: (2019) -
Pathogenesis Study of Glioma: From Glioma Stem Cells, Genomic Tags, to Rodent Models
Published: (2023) -
Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy
by: Xin Zhang, et al.
Published: (2023)